EUVIMEDDescoperă EUVIMED
Systematische ÜbersichtOpen access · CC BY-NC-ND 4.0

A systematic review of the efficacy and safety of turmeric in the treatment of digestive disorders

Kednapa Thavorn iD, Dianna Wolfe iD, Lena Faust, Risa Shorr, Maya Akkawi, Wanrudee Isaranuwatchai, Christopher Klinger, Chatree Chai-Adisaksopa, Pimwara Tanvejsilp, Surapon Nochaiwong, Sharon E Straus, Brian Hutton

Phytotherapy Research · 2024-06 · 38 (6) · 2687-2706

DOI: 10.1002/ptr.8189 ↗

At a glance

Systematische Übersicht in Phytotherapy Research, published online on 2024-03-19. Written by Kednapa Thavorn and 11 co-authors. Institution: Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada. Major MEDLINE topics: Curcuma. Cited 9 times so far (Crossref); 56 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NCCIH NIH HHS, Li Ka Shing Post-doctoral Fellowship Program, National Center for Complementary and Integrative Health of the National Institutes of Health.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Turmeric has been gaining popularity as a treatment option for digestive disorders, although a rigorous synthesis of efficacy has not been conducted. This study aimed to summarize the evidence for the efficacy and safety of turmeric in the treatment of digestive disorders, including inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), dyspepsia, gastroesophageal reflux disease, and peptic ulcers. Literature searches were conducted in Medline, EMBASE, AMED, the Cochrane Central Register of Control Trials, and Dissertation Abstracts from inception to November 15, 2021. Dual independent screening of citations and full texts was conducted and studies meeting inclusion criteria were retained: randomized controlled trials (RCT) and comparative observational studies evaluating turmeric use in people of any age with one of the digestive disorders of interest. Extraction of relevant data and risk of bias assessments were performed by two reviewers independently. Meta‐analysis was not conducted due to high heterogeneity. From 1136 citations screened, 26 eligible studies were retained. Most studies were assessed to have a high risk of bias, and many had methodological limitations. Descriptive summaries suggest that turmeric is safe, with possible efficacy in patients with IBD or IBS, but its effects were inconsistent for other conditions. The efficacy of turmeric in digestive disorders remains unclear due to the high risk of bias and methodological limitations of the included studies. Future studies should be designed to include larger sample sizes, use rigorous statistical methods, employ core outcome sets, and adhere to reporting guidance for RCTs of herbal interventions to facilitate more meaningful comparisons and robust conclusions.

Subjects

MeSH terms (MEDLINE)

CurcumaHumansRandomized Controlled Trials as TopicPlant ExtractsIrritable Bowel SyndromeInflammatory Bowel DiseasesDigestive System Diseases

Author keywords

curcumindigestive disordersefficacysafetysystematic reviewturmeric

Substances

Plant Extractsturmeric extract

Authors and institutions

  • Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
  • School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
  • Pharmacoepidemiology and Statistics Research Center (PESRC), Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
  • Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
  • McGill International Tuberculosis Centre, McGill University, Montreal, Canada.
  • Health Intervention and Technology Assessment Program, Ministry of Public Health, Bangkok, Thailand.

ORCID profiles: Kednapa Thavorn, Dianna Wolfe

Funding

  • NCCIH NIH HHS
  • Li Ka Shing Post-doctoral Fellowship Program
  • National Center for Complementary and Integrative Health of the National Institutes of Health

Cite

APA

Thavorn, K., Wolfe, D., Faust, L., Shorr, R., Akkawi, M., Isaranuwatchai, W., Klinger, C., Chai-Adisaksopa, C., Tanvejsilp, P., Nochaiwong, S., Straus, S. E., & Hutton, B. (2024). A systematic review of the efficacy and safety of turmeric in the treatment of digestive disorders. Phytotherapy Research, 38(6), 2687-2706. https://doi.org/10.1002/ptr.8189

Vancouver

Thavorn K, Wolfe D, Faust L, Shorr R, Akkawi M, Isaranuwatchai W, et al. A systematic review of the efficacy and safety of turmeric in the treatment of digestive disorders. Phytotherapy Research. 2024;38(6):2687-2706. doi:10.1002/ptr.8189

BibTeX
@article{Thavorn2024,
  author = {Thavorn, Kednapa and Wolfe, Dianna and Faust, Lena and Shorr, Risa and Akkawi, Maya and Isaranuwatchai, Wanrudee and Klinger, Christopher and Chai-Adisaksopa, Chatree and Tanvejsilp, Pimwara and Nochaiwong, Surapon and Straus, Sharon E and Hutton, Brian},
  title = {A systematic review of the efficacy and safety of turmeric in the treatment of digestive disorders},
  journal = {Phytotherapy Research},
  year = {2024},
  volume = {38},
  number = {6},
  pages = {2687--2706},
  doi = {10.1002/ptr.8189}
}
Start for free →